AstraZeneca and Daiichi Sankyo have welcomed the confirmation that the PBS listing of ENHERTU (trastuzumab deruxtecan) will be expanded on 1 September to include more women with a form of metastatic breast cancer. …
'We will continue to advocate for earlier, faster, fairer access to medicines for the benefit of all Australians'
August 29, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Just because the system involves humans, it does not make it human
August 14, 2025 - - Latest News -
Australian company Mirugen secures backing to process cell technology
August 13, 2025 - - Latest News -
AccessCR’s awards celebrate partnerships between lived experience and science
August 13, 2025 - - Latest News -
Firebrick says Nasodine COVID-19 patent accepted in Europe
August 13, 2025 - - Australian Biotech -
Orthocell advances US rollout of nerve repair product Remplir
August 13, 2025 - - Australian Biotech -
AVITA Medical successfully completes Australian equity raise
August 13, 2025 - - Australian Biotech -
Experienced innovation leader joins AusBiotech as its Head of Investment
August 13, 2025 - - Australian Biotech